BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6703927)

  • 1. Prevention of platelet deposition and thrombus formation on hemodialysis membranes: a double-blind randomized trial of aspirin and dipyridamole.
    Salter MC; Crow MJ; Donaldson DR; Roberts TG; Rajah SM; Davison AM
    Artif Organs; 1984 Feb; 8(1):57-61. PubMed ID: 6703927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin and dipyridamole reduce platelet deposition on prosthetic femoro-popliteal grafts in man.
    Goldman MD; Simpson D; Hawker RJ; Norcott HC; McCollum CN
    Ann Surg; 1983 Dec; 198(6):713-6. PubMed ID: 6227296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy for vascular prosthesis: an experimental model testing platelet inhibitory drugs.
    McCollum CN; Crow MJ; Rajah SM; Kester RC
    Surgery; 1980 Jun; 87(6):668-76. PubMed ID: 6445604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microthrombus formation on hemodialysis membranes: a placebo controlled randomized trail of two doses of Indobufen.
    Salter MC; Mayor P; Crow MJ; Rajah SM; Davison AM
    Clin Nephrol; 1985 Jul; 24(1):31-6. PubMed ID: 3893815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of thrombus formation by low-dose acetylsalicylic acid, dipyridamole, and their combination in a model of platelet-vessel wall interaction.
    Müller TH
    Neurology; 2001; 57(5 Suppl 2):S8-S11. PubMed ID: 11552048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial of dipyridamole-aspirin in recurring venous thrombosis.
    Steele P
    Lancet; 1980 Dec 20-27; 2(8208-8209):1328-9. PubMed ID: 6109150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet antagonists in migraine prophylaxis. A clinical trial using aspirin and dipyridamole.
    Masel BE; Chesson AL; Peters BH; Levin HS; Alperin JB
    Headache; 1980 Jan; 20(1):13-8. PubMed ID: 6985888
    [No Abstract]   [Full Text] [Related]  

  • 8. Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.
    Cadroy Y; Thalamas C; Sakariassen K; Boneu B
    Thromb Res; 2005; 116(4):293-300. PubMed ID: 16038713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
    Lorenz R; Siess W; Weber PC
    Eur J Pharmacol; 1981 Apr; 70(4):511-8. PubMed ID: 7238575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo.
    Müller TH; Su CA; Weisenberger H; Brickl R; Nehmiz G; Eisert WG
    Br J Clin Pharmacol; 1990 Aug; 30(2):179-86. PubMed ID: 2206782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dipyridamole and low-dose aspirin therapy on platelet adhesion to vascular subendothelium.
    Lauri D; Zanetti A; Dejana E; de Gaetano G
    Am J Cardiol; 1986 Dec; 58(13):1261-4. PubMed ID: 3788816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of platelet suppressant treatment with dipyridamole and aspirin on exercise performance and platelet survival time in coronary disease.
    Steele P; Rainwater J; Vogel R
    Chest; 1981 Nov; 80(5):557-61. PubMed ID: 7297145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of perioperative platelet inhibition on postcarotid endarterectomy mural thrombus formation. Results of a prospective randomized controlled trial using aspirin and dipyridamole in humans.
    Findlay JM; Lougheed WM; Gentili F; Walker PM; Glynn MF; Houle S
    J Neurosurg; 1985 Nov; 63(5):693-8. PubMed ID: 3903068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet inhibitory drugs: an in vivo method of evaluation in patients.
    Norcott HC; Goldman M; Hawker RJ; Rafiqi EI; Drolc Z; McCollum CN
    Thromb Haemost; 1982 Dec; 48(3):307-10. PubMed ID: 6761890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aspirin and dipyridamole on the interaction of human platelets with sub-endothelium: studies using citrated and native blood.
    Weiss HJ; Turitto VT; Vicic WJ; Baumgartner HR
    Thromb Haemost; 1981 Apr; 45(2):136-41. PubMed ID: 7256696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Anticoagulation IV: Preventing thrombosis by modifying platelet behavior.
    Adelson E; Segal A
    Med Ann Dist Columbia; 1974 Jun; 43(6):7-8. PubMed ID: 4526259
    [No Abstract]   [Full Text] [Related]  

  • 17. Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy.
    Donadio JV; Anderson CF; Mitchell JC; Holley KE; Ilstrup DM; Fuster V; Chesebro JH
    N Engl J Med; 1984 May; 310(22):1421-6. PubMed ID: 6371535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamole.
    Sinzinger H; O'Grady J; Fitscha P
    J Int Med Res; 1988; 16(1):39-43. PubMed ID: 3350203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of thrombosis in patients on hemodialysis by low-dose aspirin.
    Harter HR; Burch JW; Majerus PW; Stanford N; Delmez JA; Anderson CB; Weerts CA
    N Engl J Med; 1979 Sep; 301(11):577-9. PubMed ID: 112475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo quantitation of platelet deposition on human peripheral arterial bypass grafts using indium-111-labeled platelets. Effect of dipyridamole and aspirin.
    Pumphrey CW; Chesebro JH; Dewanjee MK; Wahner HW; Hollier LH; Pairolero PC; Fuster V
    Am J Cardiol; 1983 Mar; 51(5):796-801. PubMed ID: 6219569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.